Grace Therapeutics, Inc. (GRCE)
EBITDA Margin
-13016.77%
TTM · Period ending:
GRCE EBITDA Margin
Latest reported0.00%period ending
Latest reported0.00%period ending
GRCE FY EBITDA Margin (0.00% → 0.00%)
Annual ebitda margin
High-resolution chart · PNG
GRCE ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -5,069.8753% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -7,383.8023% | |
| -2,675.6807% | |
| -1,963.9347% | |
| -859.5253% | |
| -55,922.5107% | |
| -8,741.7182% | |
| 0% | |
| 0% |